Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pulice JL"'
Autor:
Li W; Department of Medicine, University of California, San Francisco; San Francisco, CA 94158, USA., Garcia-Rivera EM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA.; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Mitchell DC; Department of Cell Biology, Harvard Medical School; Boston, MA 02115, USA., Chick JM; Department of Cell Biology, Harvard Medical School; Boston, MA 02115, USA., Maetani M; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA.; Department of Chemistry and Chemical Biology, Harvard University; Cambridge, MA 02138, USA., Knapp JM; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Matthews GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA., Shirasaki R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA., de Matos Simoes R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA., Viswanathan V; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA.; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Rees MG; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Roth JA; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA., Gygi SP; Department of Cell Biology, Harvard Medical School; Boston, MA 02115, USA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, MA 02215, USA.; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA.; Howard Hughes Medical Institute, Harvard University; Cambridge, MA 02142, USA., Schreiber SL; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA.; Department of Chemistry and Chemical Biology, Harvard University; Cambridge, MA 02138, USA., Ostrem JML; Department of Medicine, University of California, San Francisco; San Francisco, CA 94158, USA.; Broad Institute of MIT and Harvard; Cambridge, MA 02215, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jan 28. Date of Electronic Publication: 2024 Jan 28.
Autor:
Pulice JL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Biological and Biomedical Sciences Program, Harvard University, Cambridge, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Lead contact.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 27. Date of Electronic Publication: 2023 Oct 27.
Autor:
Sandoval GJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Pakula H; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Schenone M; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Takeda DY; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Pop M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Boulay G; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Pathology and MGH Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Williamson KE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., McBride MJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Chemical Biology Program, Harvard Medical School, Boston, MA, USA., Pan J; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., St Pierre R; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Chemical Biology Program, Harvard Medical School, Boston, MA, USA., Hartman E; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Carr SA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Rivera MN; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Pathology and MGH Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Li Z; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Ronco L; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA. Electronic address: william_hahn@dfci.harvard.edu., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA. Electronic address: cigall_kadoch@dfci.harvard.edu.
Publikováno v:
Molecular cell [Mol Cell] 2018 Aug 16; Vol. 71 (4), pp. 554-566.e7. Date of Electronic Publication: 2018 Aug 02.
Autor:
McBride MJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Program in Chemical Biology, Harvard University, Cambridge, MA, USA., Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Beird HC; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Ingram DR; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., D'Avino AR; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Shern JF; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA., Charville GW; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Nakayama RT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Garcia-Rivera EM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Araujo DM; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Tsai JW; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Yeagley M; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Wagner AJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Futreal PA; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Khan J; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA., Lazar AJ; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: cigall_kadoch@dfci.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2018 Jun 11; Vol. 33 (6), pp. 1128-1141.e7. Date of Electronic Publication: 2018 May 31.
Autor:
Nakayama RT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA., Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Valencia AM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Program in Chemical Biology, Harvard University, Cambridge, Massachusetts, USA., McBride MJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Program in Chemical Biology, Harvard University, Cambridge, Massachusetts, USA., McKenzie ZM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Gillespie MA; Institute for Systems Biology, Seattle, Washington, USA., Ku WL; Systems Biology Center, NHLBI, National Institutes of Health, Bethesda, Maryland, USA., Teng M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cui K; Systems Biology Center, NHLBI, National Institutes of Health, Bethesda, Maryland, USA., Williams RT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Cassel SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Medical Scientist Training Program, Harvard Medical School, Boston, Massachusetts, USA., Qing H; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Widmer CJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Demetri GD; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA., Irizarry RA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhao K; Systems Biology Center, NHLBI, National Institutes of Health, Bethesda, Maryland, USA., Ranish JA; Institute for Systems Biology, Seattle, Washington, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Publikováno v:
Nature genetics [Nat Genet] 2017 Nov; Vol. 49 (11), pp. 1613-1623. Date of Electronic Publication: 2017 Sep 25.
Autor:
Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Williams RT; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Calarco JP; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA., Miller EL; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA., Weber CM; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA., Braun SM; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA., Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Chory EJ; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA., Crabtree GR; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Publikováno v:
Nature genetics [Nat Genet] 2017 Feb; Vol. 49 (2), pp. 213-222. Date of Electronic Publication: 2016 Dec 12.
Autor:
Pulice JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142.
Publikováno v:
Cold Spring Harbor symposia on quantitative biology [Cold Spring Harb Symp Quant Biol] 2016; Vol. 81, pp. 53-60. Date of Electronic Publication: 2017 Apr 13.